![Medigene AG logo](/logos/MDG1.DE.webp)
Medigene AG
FSX:MDG1.DE
Overview | Financials
Company Name | Medigene AG |
Symbol | MDG1.DE |
Currency | EUR |
Price | 1.76 |
Market Cap | 12,969,088 |
Dividend Yield | 0% |
52-week-range | 1.604 - 5.508 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Selwyn Ho MB BS, MBBS |
Website | https://www.medigene.com |
An error occurred while fetching data.
About Medigene AG
Medigene AG, a biotechnology company, focuses on the development of T cell immunotherapies for the treatment of cancer. The company is developing personalized T cell-based therapies with a focus on T cell receptor-modified T cells in the areas of unmet medical needs, which are in clinical development. It also focuses
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD